Azd0901

4 trials 2 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

1 Sponsors

5 Countries

Phase III

Phase II

Phase I/II

Phase III: 1 Phase II: 2 Phase I/II: 1

Indications tested

Adenocarcinoma gastric 1

Sponsors using this IMP

AstraZeneca AB 4

All trials

4 total

A study of AZD0901 alone or in combination with other anticancer drugs in patients with advanced/metastatic cancer. Recruiting

2023-508275-37-00 Phase I/II 2 countries AstraZeneca AB
Master protocol of novel combinations in participants with locally advanced unresectable or metastatic gastric or gastroesophageal junction … Recruiting

2024-510977-27-00 Phase II 1 country AstraZeneca AB
Master protocol of novel agents or combinations as perioperative treatment in participants with locally advanced resectable gastroesophagea… Ended

2024-516909-23-00 Phase II 2 countries AstraZeneca AB
A trial to learn how well AZD0901 works and how safe it is compared to standard cancer treatments in adults with advanced and metastatic gas… Ended

2023-508276-11-00 Phase III 5 countries AstraZeneca AB

Showing 1–4 of 4 trials

← All drugs A–Z